We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-1.81%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5.56B
AUM Growth
+$94.2M
(+1.7%)
Cap. Flow
+$293M
Cap. Flow
% of AUM
5.28%
Top 10 Holdings %
Top 10 Hldgs %
35.79%
Holding
4,002
New
390
Increased
2,050
Reduced
771
Closed
169
Avg Time Held Equity + Options
4.8
years
Top 10 Avg Time Held Equity + Options
3.5
years
Top 20 Avg Time Held Equity + Options
4.4
years
Avg Time Held Equity only
4.8
years
Top 10 Avg Time Held Equity only
3.5
years
Top 20 Avg Time Held Equity only
4.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$160M |
| 2 |
Avantis Emerging Markets Equity ETF
AVEM
|
+$59.5M |
| 3 |
VictoryShares Free Cash Flow ETF
VFLO
|
+$57M |
| 4 |
JPMorgan International Bond Opportunities ETF
JPIB
|
+$43M |
| 5 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$19.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$180M |
| 2 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$51M |
| 3 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$3.59M |
| 4 |
CVB Financial
CVBF
|
+$3.2M |
| 5 |
iShares International Select Dividend ETF
IDV
|
+$3.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 50.36% |
| 2 | Technology | 16.32% |
| 3 | Healthcare | 6.92% |
| 4 | Financials | 6.46% |
| 5 | Communication Services | 5.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3351
DELISTED
Northfield Bancorp
NFBK
| $1.95K | ﹤0.01% |
144
| – | – |
2024 Q2
7 quarters
|
|
3352
Hackett Group
HCKT
$281M
| $1.94K | ﹤0.01% |
149
-22
| -13% | -$352 |
2020 Q4
21 quarters
|
|
3353
Neurogene
NGNE
$473M
| $1.94K | ﹤0.01% |
+96
| New | +$1.86K |
2026 Q1
0 quarters
|
|
3354
Burke & Herbert Financial Services Corp
BHRB
$1.41B
| $1.93K | ﹤0.01% |
+31
| New | +$2K |
2026 Q1
0 quarters
|
|
3355
Third Coast Bancshares
TCBX
$693M
| $1.93K | ﹤0.01% |
+51
| New | +$2.02K |
2026 Q1
0 quarters
|
|
3356
SEALSQ Corp
LAES
$407M
| $1.92K | ﹤0.01% |
731
+706
| +2,824% | +$2.76K |
2025 Q3
2 quarters
|
|
3357
Ginkgo Bioworks
DNA
$694M
| $1.91K | ﹤0.01% |
312
-126
| -29% | -$1.05K |
2022 Q2
15 quarters
|
|
3358
Plumas Bancorp
PLBC
$435M
| $1.9K | ﹤0.01% |
+39
| New | +$1.93K |
2026 Q1
0 quarters
|
|
3359
Franklin XRP ETF
XRPZ
$202M
| $1.9K | ﹤0.01% |
+130
| New | +$2.28K |
2026 Q1
0 quarters
|
|
3360
Diebold Nixdorf
DBD
$2.26B
| $1.89K | ﹤0.01% |
25
+19
| +317% | +$1.4K |
2025 Q4
1 quarter
|
|
3361
Eaton Vance Risk-Managed Diversified Equity Income Fund
ETJ
$537M
| $1.89K | ﹤0.01% |
230
| – | – |
2018 Q3
30 quarters
|
|
3362
Janux Therapeutics
JANX
$1.02B
| $1.88K | ﹤0.01% |
135
-251
| -65% | -$3.44K |
2025 Q3
2 quarters
|
|
3363
ProShares Ultra Ether ETF
ETHT
$242M
| $1.87K | ﹤0.01% |
+125
| New | +$2.91K |
2026 Q1
0 quarters
|
|
3364
Pacer Data and Digital Revolution ETF
TRFK
$1.06B
| $1.87K | ﹤0.01% |
30
-10
| -25% | -$641 |
2025 Q4
1 quarter
|
|
3365
Viemed Healthcare
VMD
$365M
| $1.86K | ﹤0.01% |
+202
| New | +$1.68K |
2026 Q1
0 quarters
|
|
3366
Concentra Group Holdings
CON
$4.92B
| $1.84K | ﹤0.01% |
86
| – | – |
2024 Q4
5 quarters
|
|
3367
Madison Square Garden
MSGE
$3.65B
| $1.83K | ﹤0.01% |
31
+9
| +41% | +$532 |
2025 Q1
4 quarters
|
|
3368
MBX Biosciences
MBX
$2.43B
| $1.82K | ﹤0.01% |
61
| – | – |
2025 Q2
3 quarters
|
|
3369
Village Super Market
VLGEA
$646M
| $1.82K | ﹤0.01% |
43
+31
| +258% | +$1.19K |
2025 Q2
3 quarters
|
|
3370
Southside Bancshares
SBSI
$915M
| $1.8K | ﹤0.01% |
58
| – | – |
2025 Q4
1 quarter
|
|
3371
NewtekOne
NEWT
$316M
| $1.8K | ﹤0.01% |
+164
| New | +$2.08K |
2026 Q1
0 quarters
|
|
3372
Alpha and Omega Semiconductor
AOSL
$676M
| $1.79K | ﹤0.01% |
81
+79
| +3,950% | +$1.72K |
2025 Q2
3 quarters
|
|
3373
Abeona Therapeutics
ABEO
$253M
| $1.79K | ﹤0.01% |
400
| – | – |
2022 Q1
16 quarters
|
|
3374
Oportun Financial
OPRT
$421M
| $1.79K | ﹤0.01% |
+388
| New | +$1.98K |
2026 Q1
0 quarters
|
|
3375
Scansource
SCSC
$1.21B
| $1.78K | ﹤0.01% |
49
+33
| +206% | +$1.26K |
2025 Q1
4 quarters
|
|
Similar funds
Parallel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Parallel Advisors held 4,002 positions worth $5.56B, up 1.7% from $5.47B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Parallel Advisors deployed $293M of net new capital in Q1 2026, opening 390 new positions and adding to 2,050 existing holdings. Its largest new stake was JPMorgan International Bond Opportunities ETF: 883,008 shares worth $42.2M.
By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, up from 48% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares Core S&P Total US Stock Market ETF, an estimated $180M trimmed.
- Parallel Advisors's largest Q1 2026 buy was JPMorgan International Bond Opportunities ETF: 883,008 shares worth $42.2M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $160M increase.
- Parallel Advisors's biggest Q1 2026 reduction was iShares Core S&P Total US Stock Market ETF, cutting an estimated $180M.
- Parallel Advisors fully exited iShares 1-3 Year International Treasury Bond ETF in Q1 2026, selling an estimated $741K.
- Parallel Advisors's ten largest holdings make up 36% of its $5.56B portfolio in Q1 2026.
- Parallel Advisors opened 390 new positions and closed 169 in Q1 2026.
- Parallel Advisors's portfolio value rose 1.7% quarter-over-quarter to $5.56B.
Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.